SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SOROS who wrote (963)9/17/1998 4:13:00 PM
From: RBMac   of 1185
 
Completes Phase II Clinical Trial

NORTRAN PHARMACEUTICALS INC ("NTRDF-L;NRT-V") - Completes Phase II Clinical Trial

Nortran Pharmaceuticals Inc. (the "Company") announced the completion of all treatments for the
phase II clinical trials of its local anaesthetic product, RSD921. A total of 110 patients and volunteers
have now received doses ranging from 0.05 percent - 0.25 percent of RSD921. This trial was
conducted with the Company's development partner, the Chemical Company of Malaysia Berhad
("CCM"), at the University Hospital, University of Malaya.

The final reports on the trial results are expected by mid October. The data will provide a foundation for
further licensing discussions on RSD921 with pharmaceutical companies in other areas of the world,
and will be the basis for phase III clinical trials.

Nortran Pharmaceuticals is a drug discovery company focusing on pathology targeted small
molecules. The Company recently announced a partnership with F. Hoffmann La Roche covering part
of its antiarrhythmic development program in the area of atrial fibrillation. Nortran's current drugs in
development target life- threatening arrhythmias of the heart, pain management, sexual dysfunction
and acute cough. TEL: (604) 222-5577

James King, Corporate Communications TOLL FREE: 1-800-330-9928 FAX: (604) 222-6617
WEBSITE: www.nortran.com

______________________________________
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News